What the study found
The study found that women with peripartum cardiomyopathy (PPCM, heart muscle weakness around the time of pregnancy) in Uganda had high illness severity at presentation and a 7.5% death rate over 6 months. About 46.3% showed left ventricular recovery, meaning the heart’s pumping function improved to a left ventricular ejection fraction of at least 50%.
Why the authors say this matters
The authors conclude that the 7.5% mortality rate aligns with global studies, and that the thrombus burden and stroke seen in the cohort may indicate severe left ventricular systolic dysfunction at presentation. They also suggest that the frequent use of bromocriptine alongside goal-directed medical therapy may help explain the relatively high recovery rate in this group.
What the researchers tested
The researchers conducted a prospective cohort study of 80 women with PPCM in Uganda and followed them for 6 months while they received goal-directed medical therapy. At baseline and follow-up, participants had physical examinations, 12-lead electrocardiography, echocardiography, and biomarker testing, including NT-pro BNP and prolactin; 80 matched controls were also recruited at baseline for biomarker comparison.
What worked and what didn't
Among the 80 cases, the mean left ventricular ejection fraction was 35.7%, and 27.5% had a left ventricular ejection fraction below 35%. Severe right ventricular systolic dysfunction was reported in 7.5% of participants, and 25% were in New York Heart Association class IV, a measure of severe heart failure symptoms. Over 6 months, 6 participants died, atrial fibrillation occurred in 2 participants, intracardiac thrombus was documented in 8 participants, 65% were in NYHA class I, and 37 participants had left ventricular recovery.
What to keep in mind
The abstract does not describe detailed limitations beyond noting limited prior data on PPCM outcomes in Uganda. The study followed 80 women from one setting over 6 months, so the summary available here does not state how broadly the findings apply beyond this cohort.
Key points
- In this 6-month cohort of 80 Ugandan women with PPCM, 6 participants died.
- Left ventricular recovery, defined as ejection fraction of at least 50%, was seen in 46.3% of cases.
- Intracardiac thrombus was documented in 10% of participants, and atrial fibrillation occurred in 2.5%.
- At baseline, 25% of participants were in NYHA class IV and 27.5% had left ventricular ejection fraction below 35%.
- Bromocriptine was given to 68% of participants in addition to goal-directed medical therapy.
Disclosure
- Research title:
- Ugandan women with PPCM had high 6-month mortality and partial recovery
- Authors:
- Juliet Nabbaale, Karen Sliwa, Annettee Nakimuli, Graham Chakafana, Wanzhu Zhang, Peter Lwabi, John Omagino, Sulaiman Lubega, Elias Sebatta, James Kayima, Emmy Okello
- Institutions:
- Hampton University, Makerere University, Makerere University, Makerere University, Mulago Hospital, Mulago Hospital, Mulago Hospital, Mulago Hospital, Mulago Hospital, Mulago Hospital, Mulago Hospital, Mulago Hospital, University of Cape Town, University of Cape Town, University of Cape Town
- Publication date:
- 2026-01-08
- OpenAlex record:
- View
- Image credit:
- Photo by Gizem Nikomedi on Unsplash · Unsplash License
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.